Guidance

Chapter 8 - Labelling Guidance - Great Britain

UK government interpretation of the requirements for labelling e-liquids for Great Britain

Applies to England, Scotland and Wales

Documents

Chapter 8 - Labelling Guidance - GB

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Several queries have been raised with the Department of Health and MHRA, concerning the labelling provisions of the Tobacco and Related Products Regulations 2016 (TRPR) and how these should be applied to bottles of e-liquid. Given the limited space available on packs and that the text of the Directive is open to interpretation, please find below clarification on the UK Government’s interpretation of the requirements.

Please ensure you read the accompanying notes.

Great Britain will remain in alignment with TPD Article 20(4)(b) requiring certain information to appear on the ‘unit packets’ and any ‘outside packaging’ of electronic cigarettes and refill containers. Regulation 37 of the TRPR transpose the definitions of ‘unit packet’ and ‘outside packaging’ as:

a “unit pack”, in relation to a tobacco product or related product, means the smallest individual packaging in which that product is, or is intended to be, presented for retail sale (regardless of whether it is presented inside a container pack), but does not include any transparent wrapper.

a “container pack”, in relation to a tobacco product or related product means any packaging—

(a) in which that product is, or is intended to be, presented for retail sale; and

(b) which contains (whether fully or partially enclosing)—

(i) a unit pack of that product, or

(ii) an aggregation of such unit packs, and where there is more than one separate layer of such packaging, each layer is to be regarded as a separate container pack, but a transparent wrapper alone is not a container pack.

The principle that underpins the legislation is that the consumer receives the required information before purchasing. To aid understanding a number of scenarios are explored below:

1) Bottle of e-liquid with no further packaging other than an information leaflet attached to the bottle via tag or other means

The labelling requirements must be applied to the bottle, via label, pull-out label or other means.

2) Bottle of e-liquid and information leaflet placed within a cardboard box/sleeve

The cardboard box/sleeve is considered the smallest individual packaging. TRPR labelling must be applied to the cardboard box/sleeve. The bottle does not have to carry this information. Producers will wish to include information on the bottle to identify the product and ensure it can be used safely.

3) Multipack of 2 or more bottles of e-liquid or e-liquid included in a presentation box or starter kit

If the individual bottles are placed in a cardboard box/sleeve (as in point 2) TRPR labelling must be applied to both the individual cardboard box/sleeve and each subsequent layer of packaging (container pack).

Where the individual bottles not packaged and are aggregated in a multipack or presentation box, the multipack or presentation box would be considered the unit pack. In this scenario only the multipack or presentation box would require TRPR labelling. Producers will wish to include information on the bottle to identify the product and ensure it can be used safely.

Notes

  • When applying the health warning producers must adhere to the provisions on format and positioning in Regulation 37 of the TRPR
  • This guidance only relates to the TRPR labelling requirements and no other statutory requirements such as classification, labelling and packaging of chemical substances (CLP).
  • All the above examples apply equally to other forms of nicotine refill containers such as nicotine-containing cartridges.

Further information and guidance on the regulation of e-cigarettes is published on the Medicines and Healthcare products Regulatory Agency (MHRA) website.

Further information and advice on labelling on CLP can be obtained from the Health and Safety Executive.

Published 23 March 2022